Eli Lilly and Company revised earnings guidance for the year 2022. For the year, the company expects revised revenue to be in the range of $28.5 billion to $29.0 billion and earnings per share to be in the range of $6.50 to $6.65 compared to previously expected revenue to be in the range of $28.8 billion to $29.3 billion and earnings per share to be in the range of $6.96 to $7.11.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
735 USD | -2.77% | +0.20% | +26.08% |
05-03 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
05-03 | News Highlights : Top Company News of the Day - Friday at 7 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+22.62% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.23% | 198B | |
-10.88% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and Company Revises Earnings Guidance for the Year 2022